Autopsy report · NCT04764396

Assessing Effects of Heparin Priming and Pass Number on Tissue Quality of Fine Needle Biopsies

“Lack of funding and change in research direction.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 4 months before it stopped.
• 2 participants enrolled.
• Results were posted on the registry 2 years 11 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University of Michigan

Sponsor type

University, hospital or other

Conditions

Pancreas; Mass Lesion

Interventions

Heparin will be used for needle priming (BD PosiFlush™ Pre-Filled Heparin Lock Flush Syringe); Saline

Participants

2

Sites

1

Countries

United States

Trials that died the same way

• Systematic Work Environment Model Incorporating Web-based Neck-specific Exercise for Dental Staff With Neck Pain
  “Lack of fundings” (75% match in meaning)
• Metformin in Heart Failure Without Diabetes
  “Lack of funding” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.